Neogen Corporation

Equities

NEOG

US6404911066

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
11.93 USD -1.73% Intraday chart for Neogen Corporation -8.23% -40.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Neogen Corporation Forms Genomics Relationship with Performance Food Group CI
Piper Sandler Adjusts Price Target on Neogen to $17 From $19, Maintains Neutral Rating MT
Neogen®? Farm Fluid Max Disinfectant Launches Across Great Britain Livestock & Poultry Markets CI
Neogen Insider Bought Shares Worth $284,190, According to a Recent SEC Filing MT
Consumer Stocks Climb -- Consumer Roundup DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading MT
Neogen Stock Falls After Lowering Fiscal 2024 Revenue Outlook MT
Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday MT
Sector Update: Health Care MT
Transcript : Neogen Corporation, Q3 2024 Earnings Call, Apr 09, 2024
Neogen's Fiscal Q3 Adjusted Earnings Flat, Revenue Increases; Lowers 2024 Revenue Outlook MT
Caution Caps Wall Street Pre-Bell; Asia Up, Europe Down MT
Stocks Decline Pre-Bell Ahead of March Inflation Report; Asia Up, Europe Down MT
Earnings Flash (NEOG) NEOGEN CORPORATION Reports Q3 Revenue $228.8M MT
Earnings Flash (NEOG) NEOGEN CORPORATION Posts Q3 EPS $0.12 MT
Neogen Corporation Updates Earnings Guidance for the Full Year 2024 CI
Neogen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 CI
Neogen Corporation Announces Board Changes CI
Piper Sandler Adjusts Neogen's Price Target to $19 From $17.50, Maintains Neutral Rating MT
Neogen Launches New Pest Control Product MT
Neogen® Releases Surekill® Gel Bait Pro Applicator CI
Neogen Corporation Launches Provecta Pro Flea & Tick Collar for Dogs CI
Transcript : Neogen Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM
Neogen Shares Fall After Fiscal Q2 Results Decline, Fiscal 2024 Revenue Outlook Lowered MT
Chart Neogen Corporation
More charts
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.93 USD
Average target price
17 USD
Spread / Average Target
+42.50%
Consensus
  1. Stock Market
  2. Equities
  3. NEOG Stock
  4. News Neogen Corporation
  5. Sector Update: Consumer Stocks Pare Earlier Declines Monday